Abstract Book
Dear Colleagues,
It is with great pleasure that I welcome you to the 62nd National Congress of the Italian Society of Rheumatology, which is once again being held in the familiar setting of the Rimini Conference Centre, a place that has become symbolic for our scientific community.
The Congress is an essential event for all of us, not only for professional development, but also for discussion, collective growth and strengthening the bonds within our society. This year, the Congress has once again been accredited by the ECM (Italian Continuing Medical Education) to allow for even wider participation and to meet the needs of all colleagues.
The programme for this edition has been designed to offer a dynamic journey, rich in innovative content, open to interdisciplinary dialogue and future challenges.
This year marks the 75th anniversary of the founding of the SIR, and to mark the occasion, we will be organising an opening ceremony that will include a session dedicated to the evolution of rheumatology: from its historical roots to new perspectives linked to artificial intelligence, with two highly knowledgeable speakers capable of conveying passion and enthusiasm.
In addition to the plenary sessions and institutional symposia, we are also confirming the formulas that have been so successful over the years: the Hands On courses, the “Meet the Expert” sessions, the “Question Time” sessions and the traditional Review Course on Saturday morning, which will offer participants the opportunity to update themselves on topics of great practical impact.
Ample space will also be reserved for oral presentations (including those in English) and poster displays, where we will have the opportunity to take stock of the research activities of national groups. As every year, we will reward the authors of the best presentations. We are also renewing the “Verso EULAR” initiative, which highlights the contribution of our young scientific community.
Our colleagues from SIRyoung will once again be protagonists this year, with a space dedicated to them, demonstrating our ongoing commitment to the younger generation.
There will also be activities for health professionals, coordinated by For-Rheuma, and meetings with patient associations, key partners in the treatment process and in dialogue with institutions.
Once again this year, we will have our usual convivial and sporting event with the SIR RUN. After the great success of last year's edition, on Wednesday evening, running enthusiasts will be able to try their hand at two routes, 5 and 10 km, or a 5 km walking route.
As always, the success of this Congress depends on the quality of each of your contributions. I am confident that this edition will once again offer valuable insights, strengthening our sense of belonging to a vibrant, authoritative and constantly evolving Society.
In this spirit, and on behalf of the entire Executive Committee, I wish you stimulating days, rich in content and fruitful professional and personal relationships.
Enjoy the Congress!
All Items
-
PO:13:188 | Menstrual alterations among women with rheumatoid arthritis: a comparative study across treatment modalities with focus on JAK inhibitors Angelica Napoletano1, Francesca Arezzo2, Marco Fornaro1, Giuseppe Lopalco1, Gennaro Cormio2, Vincenzo Venerito1, Florenzo Iannone1. | 1University of Bari, Rheumatology Unit Department of Precision and Regenerative Medicine, Jonica Area, Bari; 2Gynecologic Oncology, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.
615 -
PO:37:260 | Mepolizumab in the treatment of patients with eosinophilic granulomatosis with polyangiitis: real-life experience from a single-center cohort Eleonora Bruschi1, Fabrizio Angeli1, Alessandro Belotti Masserini1, Stefania Bertocchi1, Silvia Breda1, Elide Lupi1, Valeria Rossi1, Tania Ubiali1, Massimiliano Limonta1 | 1ASST Papa Giovanni XXIII Bergamo Italy
228 -
PO:33:201 | Metabolic and functional state of circulating platelets in patients with systemic sclerosis Annalisa Villa1, Simona Truglia1, Francesca Maiorca2, Annamaria Sabetta2, Ludovica Lombardi2, Silvia D'Orso2, Lucia Stefanini2, Fabrizio Conti1, Marcella Visentini2, Valeria Riccieri1 | 1Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Università degli Studi di Roma La Sapienza; 2Dipartimento di Medicina Traslazionale e di Precisione, Università degli Studi di Roma La Sapienza
218 -
PO:31:173 | Methotrexate monotherapy in early systemic sclerosis: a real-life monocentric Italian experience Claudia Iannone1|2, Ilaria Magi1|2, Antonina Minniti2, Giuseppe Armentaro2, Silvia Cavalli1|2, Manuel Sette1|2, Laura Giudice1|2, Maria Rosa Pellico1|2, Cristina Bochicchio1|2, Roberto Felice Caporali1|2, Nicoletta Del Papa1|2. | 1Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Milano, Italy; 2Dipartimento di Reumatologia e Scienze Mediche, ASST G. Pini-CTO, Milano, Italy.
233 -
PO:37:267 | Mimickers of polyarteritis nodosa: a case of segmental arteriolar mediolysis Filippo Santoro1, Caterina Vacchi2, Giulia Cassone2, Maria Grazia Malandra1, Dilia Giuggioli1|2 | 1UOSD Reumatologia, Ospedale San Camillo De Lellis, Rieti; 2UOC Igiene e Sanità Pubblica, ASL Rieti; 3Direzione Sanitaria, ASL Rieti, Italy
290 -
PO:19:281 | Mitochondrial dysfunction in Still’s disease: a preliminary analysis of mtDNA copy number and TFAM expression Ludovica Manisera1, Francesca Giansanti2, Andrea Latini3, Francesca Lotito4, Serena Colafrancesco5, Angelica Gattamelata6, Fabrizio Conti7, Cinzia Ciccacci8, Roberta Priori9 | 1|6|7|9La Sapienza, Roma; 2|3|4|8Unicamillus, Roma; 5Humanitas, Milano, Italy
243 -
PO:29:139 | Modulation of autonomic dysfunction in fibromyalgia through auricular vagal nerve stimulation: preliminary results Sonia Farah1, Marco Di Carlo1, Maria Giovanna Lommano1, Benedetta Bianchi1, Piercarlo Sarzi Puttini2, Fausto Salaffi1. | 1Rheumatology Clinic, Università Politecnica delle Marche, Ospedale Carlo Urbani, Jesi, Italy; 2Rheumatology Unit, IRCCS Galeazzi-Sant Ambrogio Hospital, Milano State University School of Medicine, Milano, Italy.
243 -
PO:01:007 | Modulation of cellular senescence in psoriatic arthritis: exploring the potential impact of b/tsDMARDs treatment on telomere length, mtDNA copy number, and oxidative damage Eneida Cela1, Giada De Benedittis2, Arianna D'Antonio1, Andrea Latini3, Chiara Morgante2, Cinzia Cicacci3, Paola Conigliaro1, Mauro Fatica1, Giulia Mori1, Giuseppe Novelli2, Paola Borgiani2, Maria Sole Chimenti1. | 1Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy; 2Department of Biomedicine and Prevention, Section of Genetics, University of Rome Tor Vergata, Rome, Italy; 3UniCamillus Saint Camillus International University of Health Sciences, Rome, Italy.
246 -
PO:02:023 | Monocentric analysis of systemic glucocorticoids in PsA: the art of balancing prescriptive appropriateness and risk factor management Chiara Crotti1 2, Gilberto Cincinelli1, Giorgia Trignani13, Luca Ingrao13, Miriam Perino13, Roberto Caporali13 | 1Dipartimento di Reumatologia e Scienze Mediche - UOC Clinica Reumatologica, ASST Pini-CTO, Milano; 2Dipartimento di Reumatologia e Scienze Mediche - UOC Osteoporosi e Malattie Metaboliche dell Osso - ASST Pini-CTO, Milano; 3Dipartimento di Scienze Cliniche e di Comunità - Università degli Studi di Milano, Italy
240 -
PO:23:052 | Muscular and myocardial involvement in antisynthetase syndrome: a retrospective real-life study Giulia Buonsante1|2|3, Giacomo De Luca1|2|3, Veronica Batani1|2, Daniele Scaramuzzi1|2|3, Lorenzo Dagna1|2|3, Marco Matucci-Cerinic1|2|3, Corrado Campochiaro1|2|3. | 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital, Milano, Italy; 2Inflammation, Fibrosis and aging Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy; 3Vita-Salute San Raffaele University, Milan, Italy, Milano, Italy.
249 -
PO:15:219 | Nailfold capillaroscopic abnormalities in systemic lupus erythematosus: comparison with healthy controls and clinical-immunological correlations. Preliminary data Chiara Orlandi1|2, Alessia Loda2, Cesare Tomasi1|2, Silvia Ebe Lucia Della Pina1|2, Claudia Barison1|2, Cecilia Nalli1, Ilaria Cavazzana1|2, Micaela Fredi1|2, Franco Franceschini1|2. | 1Rheumatology and Clinical Immunology Unit - ERN ReCONNET , ASST Spedali Civili of Brescia, Brescia, Italy; 2Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
219 -
PO:14:207 | Nailfold capillaroscopy in systemic lupus erythematosus: microvascular alterations and their clinical relevance Giulia Cassone1, Filippo Santoro2, Maria Grazia Malandra2, Bruno Biasi2, Elena Vanni2, Caterina Vacchi1, Alesandra Carobbio3, Dilia Giuggioli1|2. | 1Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; 2Università di Modena e Reggio Emilia, Modena, Italy; 3Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Univeristà di Modena e Reggio Emilia, Modena, Italy.
232 -
CO:05:4 | Natural language processing reveals demographic features, comorbidities, and clinical domains to predict treatment longevity of b/tsDMARDs in psoriatic arthritis Antonio Tonutti1|2, Pierandrea Morandini3, Cosimo Faeti3, Nicoletta Luciano1|2, Saverio D'Amico3, Victor Savevski3, Carlo Selmi1|2 | 1Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; 2Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; 3Artificial Intelligence Unit, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy
107 -
PO:37:258 | Neutrophil and eosinophil extracellular traps in eosinophilic granulomatosis with polyangiitis: phenotype-based characterization and response to mepolizumab Michele Moretti1, Francesco Ferro2, Francesco Pisani1, Elisa Ferrigno1, Gaetano La Rocca1, Federica Di Cianni3, Rosaria Talarico2, Marta Mosca1, Chiara Baldini1, Ilaria Puxeddu1. | 1University of Pisa - Department of Clinical and Experimental Medicine, Pisa, Italy; 2Azienda Ospedaliero Universitaria Pisana - Rheumatology Unit, Pisa, Italy; 3University of Siena, Siena, Italy.
249 -
PO:11:172 | Not all vasculitis look the same: a difficult diagnosis Marta Arese1|2, Miriam Perino1|2, Sofia Aliprandi1|2, Antonella Murgo2, Maria Gerosa1|2, Roberto Felice Caporali1|2 | 1UOC Reumatologia AOR San Carlo, Potenza; 2Reumatologia Clinica, ASST Gaetano Pini-CTO, Milano, Italy
214 -
CO:11:6 | Off-therapy remission in systemic lupus erythematosus: the BLys lupus flare index (BLyFI) as a decision tool for immunosuppressive therapy withdrawal in remitted patients Noemi Merra1, Anna Giorgia Osele1, Davide Ragno1, Greta Hulej1, Zahrà Rahmé1, Ilenia Anna Gennaio1, Filippo Vesentini1, Margherita Zen1, Luca Iaccarino1, Andrea Doria1 | Università degli Studi di Padova, Italy
236 -
PO:34:205 | Optical coherence tomography angiography: a window on systemic sclerosis microangiopathy Martina Orlandi1, Tommaso Verdina2, Filippo Santoro1, Alessandra Carobbio3, Amelia Spinella1, Marco De Pinto1, Giorgia Roveta1, Dilia Giuggioli1 | 1Internal Medicine Residency Program, Marche Polytechnic University, Ancona; 2Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona; 3Department of Interna, Ancona, Italy
221 -
PO:34:212 | Orofacial manifestations in systemic sclerosis: preliminary observational study and update of a single-center experience Amelia Spinella1, Marco De Pinto1, Giacomo Setti2, Martina Orlandi1|3, Samuele Veronesi2, Federica Lumetti1, Alessia Laneri1, Luca Keller Sarmiento1, Giorgia Roveta1, Gilda Sandri1|3, Pierantonio Bellini2, Ugo Consolo2, Dilia Giuggioli1|3 | 1Università degli Studi di Milano, Dipartimento di Scienze Cliniche e di Comunità, Milano; 2ASST G. Pini-CTO, UOC di Clinica Reumatologica, Milano; 3UOC di Reumatologia Clinica Pediatrica, ASST Gaetano Pini-CTO, Milano, Italy
212 -
PO:11:158 | Osteomyelitis of the jaw: a rare mimick of giant cell arteritis Laura Gigante1, Giovanni B. Canestrari1, Olga Addimanda1, Francesca Bergossi1, Angela Buffa1, Francesco Cianci1, Daniela Chiarini1, Niccolò Girolimetto1, Daniele Lini1, Luca Magnani1, Mirco Magnani1, Erika Meleddu1, Francesca Pignataro1, Sofia Testoni1, Alarico Ariani1, Rita Mulè1, Elisa Rossi1, Enrica Vandelli1, Gentiana Vukatana1, Antonella Gamberini1, Massimo Reta1 | 1UO interaziendale Medicina Interna ad Indirizzo Reumatologico - AUSL Bologna - AOSP Sant'Orsola Bologna, Italy
355 -
PO:15:220 | Outcomes of extra renal flares in systemic lupus erythematosus: longitudinal analysis of a monocentric cohort Marco Oliva1, Giorgia Capozzo1, Giancarlo Cascarano1, Chiara Cardelli1, Dina Zucchi1, Angela Elia1, Elena Elefante2, Viola Signorini2, Chiara Stagnaro2, Chiara Tani1, Marta Mosca1. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2Rheumatology Unit, AOUP, Pisa, Italy.
239 -
PO:32:176 | Outcomes of upfront combination vs monotherapy with rituximab or mycophenolate mofetil for systemic sclerosis interstitial lung disease: results from a European Scleroderma Trials and Research cohort study Devis Benfaremo1, Corrado Campochiaro2, Gábor Kumánovics3, Christina Bergmann4, Elisabetta Zanatta5, David Launay6, Serena Guiducci7, Mickael Martin8, Carolina De Souza Müller9, Carlomaurizio Montecucco10, Luc Mouthon11, Gabriella Szucs12, Kastriot Kastrati13, Marie-Elise Truchetet14, Madelon Vonk15, Francesco Del Galdo16, Marco Matucci-Cerinic2, Gianluca Moroncini1, Yannick Allanore17. | 1Department of Clinical and Molecular Sciences, Marche Polytechnic University, Marche University Hospital, Ancona, Italy; 2Vita-Salute San Raffaele University, San Raffaele Hospital, Milano, Italy; 3University of Pécs, Department Of Rheumatology And Immunology, Pécs, Hungary; 4University Hospital Erlangen, Department Internal Medicine 3, Erlangen, Germany; 5Padova University Hospital, Rheumatology Unit, Padova, Italy; 6Univ. Lille, Inserm, CHU Lille, Department of Internal Medicine and Clinical Immunology, Lille, France; 7University of Florence, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy; 8Poitiers University Hospital, Department of Internal Medicine Poitiers France; 9Hospital de Clinicas da Universidade Federal do Parana Curitiba Brazil; 10Università di Pavia e IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy; 11Hôpital Cochin, Department of Internal Medicine, Paris, France; 12University of Debrecen, Faculty of Medicine, Department of Rheumatology, Debrecen, Hungary; 13Medical University of Vienna, Department of Medicine III, Division of Rheumatology, Vienna, Austria; 14CHU de Bordeaux, Rheumatology department, Bordeaux, France; 15Radboudumc, Department of Rheumatology Nijmegen The Netherlands; 16Leeds Raynauds and Scleroderma Program, NIHR Biomedical Research Centre, Leeds, United Kingdom; 17Université Paris Cité, Cochin Hospital, Rheumatology Department, Paris, France.
261 -
PO:25:083 | Overlap between Sjögren’s syndrome and lichen sclerosus: beyond coincidence? Emanuele Giovanni Grilli1, Ludovica Manisera1, Ilenia Fischetti1, Linda Mastromanno1, Martina Villa1, Angelica Gattamelata1, Fabrizio Conti1, Roberta Priori1|2, Serena Colafrancesco3|4 | 1Dipartimento di Medicina e Chirurgia, Università Milano-Bicocca; 2U.O. Reumatologia, IRCCS Fondazione San Gerardo dei Tintori, Monza; 3U.O. Pneumologia, IRCCS Fondazione San Gerardo dei Tintori, Monza; 4Rheumatology and Clinical Immunology, Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS Humanitas Research Hosp, Rozzano, Milano, Italy
350 -
PO:23:055 | Overlap of systemic sclerosis and Sjögren’s disease: insights from an Italian case-control study Stefano Stano1, Fabio Cacciapaglia1|2, Maria Morrone1, Simone Perniola1, Marco Capodiferro1, Marco Fornaro1, Laura Coladonato1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Rheumatology Unit - Department of Precision and Regenerative Medicine, Jonian Area DiPReMeJ, University of Bari, Bari, Italy; 2Rheumatology Service, Internal Medicine Unit F. Miulli General Hospital, Department of Medicine and Surgery, LUM Casamassima Italy.
363 -
CO:08:4 | Paraproteinemias in Sjögren’s disease: cryoglobulinemia and monoclonal component define distinct phenotypes with a synergistic lymphoproliferative risk Maria Teresa Rizzo1, Simone Longhino1, Giacomo Cafaro2, Valeria Manfrè1, Francesco Carubbi3, Alessia Alunno3, Piera Altieri3, Nicoletta Del Papa4, Paola Cipriani5, Fabiola Atzeni6, Francesca Cracò6, Onorina Berardicurti7, Andrea Pilato7, Roberta Priori8, Angelica Gattamelata8, Serena Guiducci9, Chiara Baldini10, Beatrice Dei10, Pamela Bernardini9, Elena Bartoloni2, Luca Quartuccio1 | 1Clinica di Reumatologia, Ospedale Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale AS Udine; 2SC Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia; 3Unità operativa di Medicina Interna e Nefrologia, Dipartimento delle Scienze della Vita, della Salute e dell Ambiente L'Aquila; 4Unità operativa di Sclerodermia, Dipartimento di Reumatologia, ASST G. Pini-CTO, Università degli Studi di Milano; 5Unità operativa di Reumatologia, Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università dell'Aquila; 6UOC di Reumatologia, Dipartimento di Medicina Interna e Sperimentale, Università di Messina; 7UOC di Immuno-Reumatologia, Dipartimento di Medicina e Chirurgia, Università Campus Bio-Medico di Roma; 8UOC Reumatologia, Sapienza Università di Roma; 9SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; 10Clinica di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa, Italy
1051 -
PO:35:228 | Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors for cancer treatment: a systematic review and meta-analysis highlighting differences from the idiopathic forms Elvis Hysa1, Andrea Casabella2, Emanuele Gotelli1, Rosanna Campitiello1, Carlo Genova3, Enrica Teresa Tanda4, Carmen Pizzorni1, Alberto Sulli1, Vanessa Smith5, Marco Amedeo Cimmino6, Sabrina Paolino1, Maurizio Cutolo1. | 1Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, Genova, Italy; 2IRCCS Ospedale Policlinico San Martino, Genova, Italy; 3Academic Oncology Unit; IRCCS Ospedale Policlinico San Martino, Genova, Italy; 4UOC Medical Oncology Clinic 2, Department of Internal Medicine, University of Genova, Genova, Italy; 5Department of Internal Medicine, Ghent University, Department of Rheumatology, Ghent University Hospital, Ghent, Belgium; 6Rheumatology Outpatient Clinic, Villa Ravenna Chiavari Italy.
241 -
PO:34:217 | Possible role of phosphodiesterase type 5 inhibitors in the prevention of digital ulcers and videocapillaroscopic changes in patients with systemic sclerosis Elena Platania1, Marius Cadar1, Ilaria Bisconti1, Davide Mohammad Reza Beigi1|2, Francesca Romana Di Ciommo1, Jacopo Landro1, Martina Salerno1, Beatrice De Girolamo1, Simona Truglia1, Fabrizio Conti1, Valeria Riccieri1 | 1S.C. Reumatologia; 2S.C. Reumatologia
265 -
PO:15:222 | Post-hoc analysis of the BeRLiSS-JS registry: efficacy of belimumab on thrombocytopenia Greta Hulej1, Margherita Zen1, Marisol Bracalenti1, Francesca Bottazzi2, Rossella De Angelis3, Giacomo Emmi4, Roberto Gerli5, Marcello Govoni6, Renato Lo Gullo7, Simone Negrini8, Luca Quartuccio9, Maurizio Rossini10, Carlo Salvarani11, Paola Tomietto4, Angelo Vacca12, Andrea Doria1, Luca Iaccarino1. | 1Università degli Studi di Padova, Padova, Italy; 2Università degli Studi di Pavia, Pavia, Italy; 3Università Politecnica delle Marche, Ancona, Italy; 4Università degli Studi di Trieste, Trieste, Italy; 5Università degli Studi Perugia, Perugia, Italy; 6Università degli Studi di Ferrara, Ferrara, Italy; 7Università degli Studi di Catania, Catania, Italy; 8Università degli Studi di Torino, Torino, Italy; 9Università degli Studi di Udine, Udine, Italy; 10Università degli Studi di Verona, Verona, Italy; 11Università degli Studi di Modena e Reggio Emilia, Modena, Italy; 12Università degli Studi di Bari .
239 -
PO:20:014 | Post-partum osteoporosis: severe clinical presentation in absence of known risk factors Domenico Birra1, Ludovica Frances Grasso2, Vittoria Gammaldi1, Antonietta De Sena1, Carmine Pio Petrosino2, Rosalia Boccia2, Gabriella Oliva1, Vincenzo Nuzzo1 | 1Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma; 2Istituto Superiore di Sanità, Roma
244 -
CO:12:4 | Predicting 12-month clinical relapse in Takayasu arteritis using [18F]FDG PET and convolutional neural networks Alessandro Tomelleri1, Carolina Bezzi2, Sara Resta2, Corrado Campochiaro1, Federico Fallanca2, Elena Baldissera1, Samuele Ghezzo2, Nicola Farina1, Arturo Chiti2, Paola Mapelli2, Marco Matucci-Cerinic1, Maria Picchio2, Lorenzo Dagna1. | 1IRCCS Ospedale San Raffaele, Unità di Immunologia Reumatologia Allergologia e Malattie Rare, Milano; 2IRCCS Ospedale San Raffaele, Unità di Medicina Nucleare, Milano, Italy
269 -
CO:05:1 | Predicting one-year disease activity in systemic lupus erythematosus using machine learning and explainable AI Pier Giacomo Cerasuolo1, Augusta Ortolan1, Livia Lilli2, Laura Antenucci2, Carlotta Maschiocchi2, Jacopo Lenkowicz2, Lucia Lanzo1, Luca Petricca1, Maria Rita Gigante1, Vivianaantonella Pacucci1, Pierluigi Rizzuti1, Rebecca Ventura1, Silvia Piunno1, Cesare Gavotti1, Marco Gorini3, Gabriella Castellino3, Alfredo Cesario2, Stefano Patarnello2, Silvia Laura Bosello1, Maria Antonietta D'Agostino1. | 1UOC di Reumatologia ed Immunologia Clinica, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma; 2Gemelli Generator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma; 3AstraZeneca Italy, MIND, Milano, Italy
313 -
PO:07:102 | Predicting success with baricitinib in rheumatoid arthritis: efficacy across ages and serological profiles Daniele Lini1, Matteo Colina2, Romina Andracco3, Francesca Ometto4, Viviana Ravagnani5, Alberto Lo Gullo6, Simone Parisi7, Antonella Farina8, Patrizia Del Medico9, Marino Paroli10, Olga Addimanda1, Alessandra Bezzi11, Federica Lumetti12, Aldo Biagio Molica Colella13, Davide Murgia14, Maddalena Larosa15, Aurora Ianniello16, Elena Bravi17, Marta Priora18, Palma Scolieri19, Alessandro Volpe20. | 1Azienda Unità Sanitaria Locale di Bologna -- Policlinico S.Orsola- Azienda Ospedaliera Universitaria-IRCCS di Bologna, Bologna; 2Rheumatology Service. Department of Medicine and Oncology, Ospedale Santa Maria della Scaletta, Imola; 3Imperia Hospital, Internal Medicine Unit, Rheumatology outpatient clinic, Imperia; 4Azienda ULSS 6 Euganea, Rheumatology Outpatient Clinic, Padova; 5Santa Chiara Hospital APSS Trento, Rheumatology Unit, Trento; 6ARNAS Garibaldi di Catania, Rheumatology Unit, Catania; 7Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Rheumatology Department, Torino; 8Ospedale A. Murri di Fermo, Internal Medicine Unit, Rheumatology outpatient clinic, Fermo; 9Civitanova Marche Hospital, Rheumatology outpatient clinic - Internal Medicine Unit, Civitanova Marche; 10Sapienza University of Rome, Polo Pontino, Department of Clinical, Anesthesiological and Cardiovascular Sciences, Latina; 11ASL Romagna Rimini, Internal Medicine and Rheumatology Unit, Rimini; 12Azienda USL of Modena and University Hospital Policlinico di Modena, Rheumatology Unit, Modena; 13Rheumatology Unit, Azienda Ospedaliera Papardo, Messina; 14ASL VC Ospedale S. Andrea, Unit of Rheumatology, Vercelli; 15Azienda Sanitaria Locale 3 Genova, Division of Rheumatology - Medical Specialties Department, Genova; 16ASL Novara, Rheumatology Outpatient Unit, Novara; 17Ospedale G. Da Saliceto, Rheumatology Unit, Piacenza; 18ASL CN1, Rheumatology Day Hospital and outpatient clinic, Mondovì (CN); 19Nuovo Regina Margherita Hospital, Department of Medical Specialties, Roma; 20IRCCS Sacro Cuore Don Calabria Hospital, Unit of Rheumatology, Negrar, Italy.
234 -
CO:06:1 | Predictors of damage accrual in a monocentric cohort of patients with Behçet’s syndrome (BS) evaluated with BS overall damage index in real-life clinical practice Giulia Voltarel1|2, Francesca Crisafulli1|2, Alba Chiara Pozzi1|2, Anita Melzani2, Micol Frassi1, Ilaria Cavazzana1|2, Franco Franceschini1|2, Paolo Airò1. | 1Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia; 2Department of Clinical and Experimental Sciences, University of Brescia, Italy
259 -
PO:24:070 | Preliminary descriptive data from a single-centre cohort of patients with idiopathic inflammatory myopathy: focus on paraneoplastic and non-paraneoplastic patients Silvia Ebe Lucia Della Pina1, Paola Bizioli1, Samantha Mazza2, Caproli Alessia1, Cesare Tomasi1, Ilaria Cavazzana1, Franco Franceschini1. | 1S.C.O. Reumatologia ed Immunologia Clinica, ASST Spedali Civili di Brescia, Università degli Studi di Brescia, Brescia, Italy; 2Università degli Studi di Brescia, Brescia, Italy.
201 -
PO:16:241 | Prevalence and associated factors of premature ovarian insufficiency in women with systemic lupus erythematosus: the role of human herpesviruses HHV-7 and HHV-8 Margherita Rizzo1, Francesca Ruffilli1, Silvia Beltrami2, Daria Bortolotti2, Roberta Rizzo2, Carlo Garaffoni1, Ettore Silvagni1, Marcello Govoni1, Alessandra Bortoluzzi1 | 1UOC Reumatologia, Dipartimento di Scienze Mediche, Università di Ferrara e Azienda Ospedaliero-Universitaria S. Anna, Ferrara; 2Dipartimento di Scienze Chimiche, Farmaceutiche e Agrarie, Ferrara Italy
248 -
PO:31:165 | Prevalence and incidence of skin telangectasia and their association with clinical features: analysis of the European Scleroderma Trials and Research cohort Gemma Lepri1, Lorenzo Tofani2, Silvia Bellando Randone1, Veronica Batani3, Paolo Airò4, Patricia Carreira5, Joerg Henes6, Alexandra Balbir Gurman7, Florenzo Iannone8, Antonella Marcoccia9, Luc Mouthon10, Branimir Anic11, Carolina De Souza Müller12, Armine Haroyan13, Ana Cristina Cordeiro14, Serena Guiducci And Eustar Coll1. | 1University of Florence, Dept of Experimental and Clinical Medicine, AOU Careggi, Division of Rheumatology Florence Italy; 2University of Florence, Dept of Statistics, Informatics, Applications, Florence, Italy; 3Unit of Immunology, Rheumatology, Allergy and Rare Diseases UnIRAR, IRCCS San Raffaele, Milano, Italy; 4Scleroderma Unit, UOC Rheumatology and Clinical Immunology, ASST Spedali Civili, Brescia, Italy; 5Dept of Rheumatology, 12 de Octubre University Hospital, Madrid, Spain; 6Centre for Interdisciplinary Rheumatology, Immunology and autoimmune diseases INDIRA, University Hospital Tuebingen, Tuebingen, Germany; 7Rheumatology Institute, Rambam Health Care Campus Haifa Israel; 8Dept of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy; 9Interdisciplinary Reference Center for Systemic Sclerosis CRIIS Sandro Pertini Hospital, Rome, Italy; 10Dept of Internal Medicine, Cochin Hospital, Paris Cité University, Paris, France; 11Div Clinical Immunology and Rheumatology, Dept Internal Medicine, School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia; 12Rheumatology Division, Hospital de Clínicas da Universidade Federal do Parana, Curitiba, Brazil; 13Dept of Rheumatology, Yerevan State Medical University of Armenia, Yerevan, Armenia; 14Servico Reumatologia Hospital Garcia de Orta Almada, Almada, Portugal.
241 -
S05:6 | Prevalence of osteoporosis and bone mineral metabolism disorders in an Italian cohort of patients with microcrystalline arthritis: results from the PREMIA observational study of the Italian Society of Rheumatology Silvia Grignaschi1, Sonia Farah2, Silvia Balduzzi1, Bernd Raffeiner3, Carlomaurizio Montecucco4, Fausto Salaffi2, Enrico Selvi5, Annamaria Iagnocco6, Fabiola Atzeni7, Serena Guiducci8, Rosario Foti9, Maria Manara10, Marcello Govoni11, Carlo Selmi12, Francesca Oliviero13, Roberta Ramonda13 | 1ASST Pavia; 2Ospedale Carlo Urbani Jesi Italy; 3Azienda Sanitaria dell'Alto Adige, Bolzano; 4IRCCS Fondazione Policlinico San Matte, Pavia; 5AOU Senese, Siena; 6Ospedale MAuriziano, Torino; 7Università di Messina; 8AOU Careggi, Firenze; 9AOU Policlinico G. Rodolico, Catania; 10ASST Gaetano Pini-CTO Milano; 11AUSL Ferrara; 12Humanitas San Pio X, Milano; 13AOU Padova, Italy
214 -
CO:08:6 | Prevalence, incidence and survival in interstitial lung disease secondary to primary Sjögren’s syndrome. Results from the “EMERGE” longitudinal study Alessandra Rai1, Caterina Vacchi2, Stefania Cerri3, Roberta Eufrasia Ledda4, Giulia Cassone2, Dario Andrisani3, Filippo Gozzi3, Lucia Dardani1, Fabiola Atzeni5, Athina Patsoura3, Francesca Cozzini1, Marco Sebastiani6, Andreina Manfredi1. | 1USL-IRCCS Reggio Emilia, University of Modena and Reggio Emilia; 2Azienda Ospedaliero Universitaria Policlinico di Modena; 3 Pulmonology Unit, AOU Policlinico di Modena, University of Modena and Reggio Emilia; 4Radiology Unit, Azienda Ospedaliera di Parma, University of Parma; 5 Policlinico Gaetano Martino, University of Messina; 6Azienda Ospedaliera di Piacenza,University of Parma, Italy
588 -
PO:17:248 | Prevention of human papillomavirus infection in women with systemic lupus erythematosus: a single-center cross-sectional study Clizia Gagliardi1, Maria Chiara Gerardi1, Bianca Lucia Palermo1, Giulia Carrea1, Maria Di Cicco1, Elena Manna1, Giulia Segatto1, Antonella Adinolfi1, Laura Belloli1, Cinzia Casu1, Silvia Cavalli1, Davide Antonio Filippini1, Matteo Longhi1, Gabriella Maioli1, Martina Schettino1, Nicola Ughi1, Elisa Verduci1, Arianna Bertolucci1, Lara Buffa1, Giulia Buonsante1, Claudia Cordini1, Eleonora Giacobbe1, Francesco Molica Colella1, Oscar Epis1 | 1ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
255 -
PO:14:205 | Primary antiphospholipid antibody syndrome: association between new classification criteria manifestations and a higher-risk disease phenotype Sara Ferrigno1, Vittorio Forte2, Marco Panetta1, Sergio Lisena1, Giorgia Ranucci2, Luigi De Marco1, Elisabetta Greco1, Alberto Bergamini1, Maria Sole Chimenti1, Paola Conigliaro1. | 1Rheumatology, allergology and clinical immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 2Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
246 -
PO:25:082 | Progressive interstitial lung disease secondary to Sjögren's disease in a patient with inclusion body myositis complicated by dysphagia: a multidisciplinary approach and therapeutic challenges Emanule Cocchiara1, Francesco Falco1, Lucia Spaggiari3, Francesca Cozzini1|2, Lucia Dardani1, Gianluigi Bajocchi1, Andreina Manfredi1|2, Carlo Salvarani1|2 | 1Dipartimento di Medicina, Clinica Reumatologica, Udine; 2Università degli studi di Modena e Reggio Emilia, Modena; 3AUSL area NORD, Guastalla-Montecchio, Italy
262 -
PO:15:221 | Proteins upregulated in thrombotic antiphospholipid syndrome link to platelet function in contrast with non-antiphospholipid-related thrombosis: insights from two systematic reviews Silvia Mancuso1, Claudia Ciancarella1, Luca Rapino1, Simona Truglia1, Cristiano Alessandri1, Fabrizio Conti1. | 1Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari - Rheumatology Unit, Sapienza Univers, Roma, Italy.
231 -
PO:03:036 | Psoriatic arthritis: does pre-existing treatment with cs/bDMARDs for psoriasis influence the characteristics and outcomes of joint disease? Ilenia Marchesini1, Alberto Floris1, Cristina Mugheddu2, Laura Li Volsi1, Maria Teresa Paladino1, Roberta Origa1, Jessica Sorgia1, Mattia Congia1, Elisabetta Chessa1, Matteo Piga1, Caterina Ferreli2, Laura Atzori2, Alberto Cauli1 | 1Unità di Reumatologia, AOU e Università di Cagliari-Monserrato; 2Unità di Dermatologia, AOU e Università di Cagliari, Italy
276 -
PO:10:154 | Pudendal nevralgia as an unusual presenting symptom of axial spondyloarthritis Benedetta Bongiovanni1, Gabriele Amati1, Gilda Sandri1|2, Giovanni Ciancio2, Dilia Giuggioli1|2 | 1Struttura complessa di Reumatologia, azienda ospedaliera universitaria Policlinico di Modena; 2Cattedra di Reumatologia, università degli studi di Modena e Reggio Emilia, Modena, Italy
333 -
PO:25:073 | Pulmonary involvement and progressive interstitial lung disease in anti-synthetase syndrome: a single-center retrospective study Daniele Scaramuzzi1|3, Giacomo De Luca1|3, Veronica Batani1, Giulia Buonsante1|3, Lorenzo Dagna1|3, Marco Matucci-Cerinic1|2|3, Corrado Campochiaro1|2|3 | 1Unità di Immunologia, Reumatologia, Allergologia e Malattie Rare, IRCCS Ospedale San Raffaele, Milano; 2Inflammation, Fibrosis and Ageing Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano; 3Università Vita-Salute San Raffaele, Milano, Italy
236 -
PO:24:057 | Qualitative and quantitative analysis of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies: focus on muscle histology Jacopo Landro1, Marius Cadar1, Davide Mohammad Reza Beigi1|2, Ilaria Bisconti1, Francesca Romana Di Ciommo1, Elena Platania1, Martina Salerno1, Beatrice De Girolamo1, Annalisa Villa1, Angelica Gattamelata1, Simona Truglia1, Cristiano Alessandri1, Fabrizio Conti1, Valeria Riccieri1. | 1Policlinico Umberto I, Roma, Italy; 2Clinica Reumatologica Madonna dello Scoglio, Cotronei, Italy.
237 -
CO:07:2 | Quantitative computed tomography analysis of pulmonary disease in systemic sclerosis: correlation between radiomics and pulmonary function tests Francesco Pollastri1, Loredana Carobene2, Giovanni Adami1, Michele Pernigotto3, Federico Aldegheri1, Angela Ventura3, Claudio Micheletto2, Susanna Baltieri3, Marco Sebastiani4|6, Andreina Manfredi5, Davide Gatti1, Maurizio Rossini1, Angelo Fassio1. | 1UOC Reumatologia, Università degli Studi di Verona; 2UOC Pneumologia, Università degli Studi di Verona; 3 UOC Radiologia, Università degli Studi di Verona; 4Universita degli Studi di Parma; 5UUOC Reumatologia, Università degli Studi di Modena e Reggio Emilia; 6UOC Reumatologia, Azienda Unita' Sanitaria Locale, Piacenza, Italy
276 -
PO:23:051 | Quantitative high-resolution computed tomography analysis in Sjögren’s disease-associated interstitial lung disease: CALIPER-derived imaging biomarkers for prognostic assessment Gaetano La Rocca1, Francesco Ferro1, Vincenzo Uggenti2, Beatrice Dei1, Giovanni Fulvio1, Michele Moretti1, Chiara Romei2, Marta Mosca1, Chiara Baldini1. | 1University of Pisa, Rheumatology Unit, Clinical and Experimental Medicine Department, Pisa, Italy; 2Department of Diagnostic Imaging, Pisa University Hospital, Pisa, Italy.
231 -
CO:05:3 | Radiomics and machine learning for differentiating rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis with usual interstitial pneumonia pattern Vincenzo Venerito1, Chiara Nani2, Andreina Manfredi3, Marco Fornaro1, Giuseppe Lopalco1, Florenzo Iannone1, Cecilia Burattini2, Marco Sebastiani4. | 1Rheumatology Unit, University of Bari; 2Respiratory Unit, Guglielmo da Saliceto Civil Hospital, Piacenza; 3Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia; 4Rheumatology Unit, AUSL Piacenza, University of Parma, Italy
372 -
PO:14:195 | Real-world effectiveness of anifrolumab in achieving treatment targets and reducing systemic lupus erythematosus disease burden: 6-month interim analysis of the REVEAL study Chiara Cardelli1|2, Chiara Tani1, Luca Moroni3, Filippo Vesentini4, Francesca Bottazzi5, Micaela Fredi6, Ettore Silvagni7, Matteo Piga8, Flavia Riccio9, Fulvia Ceccarelli10, Ginevra De Marchi11, Edoardo Biancalana12, Gianluca Moroncini13, Rita Mulè14, Mariele Gatto15, Laura Coladonato16, Paola Conigliaro17, Maria Gerosa18, Andrea Picchianti Diamanti19, Benedetta Bianchi20, Federica Maiolini20, Michela Gasparotto20, Serena Guiducci20, Maria Ilenia De Andres20, Alberto Lo Gullo20, Silvia Noviello20, On Behalf Of The Reveal Investigators20, Marta Mosca1. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa; 2Department of Medical Biotechnologies, University of Siena, Siena; 3Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano; 4Rheumatology Unit, Department of Medicine, University of Padua, Padova; 5Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; 6Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, University of Brescia, Brescia; 7Section of Rheumatology, Department of Medical Sciences, University of Ferrara; AOU Sant'Anna, Ferrara; 8Rheumatology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari; 9Department of Precision Medicine, University of Campania Luigi Vanvitelli, Napoli; 10Rheumatology Unit, Dept. of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Roma; 11Division of Rheumatology, Department of Medicine, Azienda Sanitaria Universitaria del Friuli Centrale, Udine; 12Internal Interdisciplinary Medicine Unit, Department of Experimental and Clinical Medicine, University of Florence, Firenze; 13Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona; 14Azienda Ospedaliero-Universitaria di Bologna, Internal Medicine and Rheumatology, IRCCS S. Orsola Malpighi, Bologna; 15Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin; AO Mauriziano, Torino; 16Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari; 17Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University of Rome, Roma; 18Clinical Rheumatology, ASST Gaetano Pini CTO; Department of Clinical Sciences and Community Health, University of Milano, Milano; 19Department of Clinical and Molecular Medicine, Sapienza University of Rome; AOU Sant'Andrea, Roma, Italy; 20Italian REVEAL Study Group Italy, Italy
298 -
PO:35:219 | Real-world effectiveness of mepolizumab on gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome: a multicentre retrospective study Alessia Gatti1, Francesca Regola1, Giulia Fontana1, Mario Addrea Piga2, Gianluca Moroncini2, Palma Carlucci3, Angelo Vacca3, Paolo Delvino4, Enrico Heffler5, Emanuele Nappi5, Jakub Moll6, Laura Losappio6, Jan Schroeder6, Federica Davanzo7, Roberto Padoan7, Edoardo Conticini8, Paolo Cameli8, Greta Pacini9, Alvise Berti9, Lorenzo Vrola10, Paola Tomietto10, Luca Quartuccio11, Jan Willem Cohen Tervaert12, Sabrina Arnold13, Peter Lamprecht13, Florence Roufosse14, Ilaria Cavazzana1, Franco Franceschini1, Giacomo Emmi15, Paola Toniati1. | 1Rheumatology and Clinical Immunology Unit, ERN ReCONNET, ASST Spedali Civili of Brescia and University of Brescia, Italy, Brescia, Italy; 2Università Politecnica delle Marche and Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy, Ancona, Italy; 3Section of Internal Medicine 'Guido Baccelli', DiMePRe-J, University of Bari 'Aldo Moro', Bari, Italy, Bari, Italy; 4Rheumatology Unit, IRCCS San Gerardo dei Tintori, Monza, Italy Monza Italy; 5Department of Biomedical Sciences, Humanitas University and Personalized Medicine, Asthma and Allergy IRCCS Humanitas, Milano, Italy; 6Division of Allergy and Clinical Immunology, ASST GOM Niguarda, Milan, Italy, Milano, Italy; 7Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padova, Italy, Padova, Italy; 8University of Siena, Siena, Italy, Siena, Italy; 9Santa Chiara Hospital and University of Trento, Unit of Rheumatology, Trento, Italy Trento Italy; 10UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste, Italy, Trieste, Italy; 11Division of Rheumatology, Department of Medicine DMED, University of Udine, Udine, Italy, Udine, Italy; 12University of Alberta, Edmonton, Alberta, Canada and Maastricht University, Maastricht, The Netherlands Maastricht The Netherlands; 13Department of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, Germany Lubeck Germany; 14Department of Internal Medicine, Hôpital Universitaire de Bruxelles - Erasme, Université Libre de Bruxelles, Belgium Brussels Belgium; 15Clinical Medicine and Clinical Immunology and Rheumatology Unit Cattinara University Hospital and University of Trieste, Trieste, Italy.
302